Skip to main content

Table 2 Correlation analysis of SCC antigen levels with clinical characteristics of patients with cervical squamous cell carcinoma

From: Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Clinical characteristics

Conventional group

NACT group

SCC antigen

ISCC

SSCC

OSCC

FSCC

TSCC

FSCC (%)

TSCC (%)

Age

Spearman CC

0.204

0.064

0.095

0.134

0.073

0.037

0.102

0.057

P value

0.220

0.616

0.457

0.295

0.565

0.774

0.421

0.655

Tumor differentiation degree

Spearman CC

0.076

0.111

0.195

0.117

0.109

0.158

−0.016

0.126

P value

0.644

0.381

0.123

0.359

0.389

0.212

0.903

0.323

Number of positive lymph nodes

Spearman CC

0.673

0.326

0.436

0.395

0.237

0.274

0.060

0.089

P value

< 0.001

0.009

< 0.001

0.001

0.059

0.029

0.637

0.484

Maximum length of the lesion before chemotherapy

Spearman CC

0.643

0.352

0.217

0.212

0.429

0.402

0.383

0.283

P value

< 0.001

0.004

0.085

0.096

< 0.001

0.001

0.002

0.023

Maximum length of the lesion after chemotherapy

Spearman CC

–

0.046

0.142

0.183

0.019

0.040

−0.020

−0.075

P value

–

0.718

0.263

0.151

0.880

0.754

0.874

0.558

Narrowing extent of the lesion

Spearman CC

–

0.326

0.083

0.003

0.413

0.391

0.387

0.424

P value

–

0.008

0.515

0.980

0.001

0.001

0.002

<0.001

Survival time

Spearman CC

−0.060

−0.154

−0.263

−0.265

−0.086

− 0.030

0.033

0.111

P value

0.716

.0.227

0.037

0.037

0.502

0.816

0.800

0.387

  1. CC Correlation Coefficient, SCC antigen Squamous cell carcinoma antigen, ISCC The SCC antigen level before the first chemotherapy, SSCC The SCC antigen level after the first chemotherapy, OSCC The SCC antigen level after the second chemotherapy, FSCC The absolute value of the decreased SCC antigen level after the first chemotherapy, TSCC The absolute value of the decreased SCC antigen level after total chemotherapy, FSCC (%) Percentage decrease in SCC antigen level after the first chemotherapy, TSCC (%) Percentage decrease in SCC antigen level after total chemotherapy